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ABSTRACT
Introduction Violence against women is a global 
public health concern; around a quarter of women will 
experience intimate partner physical or sexual violence 
during their lifetime. We assessed the impact of a gender 
transformative intervention for women designed to prevent 
intimate partner violence (IPV).
Methods We conducted a cluster randomised controlled 
trial in Mwanza city, Tanzania, among women in newly 
formed neighbourhood groups to evaluate a 10- session 
participatory intervention that aims to empower women, 
prevent IPV and promote healthy relationships. Following 
a baseline interview, groups were randomly assigned (1:1 
ratio) to the intervention or control arm. An intention- to- 
treat analysis was conducted to assess the impact of the 
intervention on the main outcomes, assessed 24 months 
postintervention. These included past- year physical IPV 
and sexual IPV (primary); past- year emotional abuse; and 
acceptability and tolerance of IPV.
Results Between September 2015 and February 2017, 
1265 women were recruited in 66 neighbourhoods and 
randomly allocated to intervention (n=627 women in 
33 neighbourhoods) or control (n=638 women in 33 
neighbourhoods). Assessment of outcomes was completed 
for 551 (88%) intervention and 575 (90%) control women. 
Among intervention women, 113 (21%) reported physical 
IPV compared with 117 (20%) control women (adjusted OR 
(aOR) 0.98, 95% CI 0.72 to 1.33, p=0.892), and 109 (20%) 
intervention women reported sexual IPV compared with 
121 (21%) control women (aOR 0.98, 95% CI 0.72 to 1.32, 
p=0.881). Intervention women reported less emotional 
abuse (aOR 0.74, 95% CI 0.56 to 0.98, p=0.035), and were 
less likely to express attitudes accepting of IPV (aOR 0.49, 
95% CI 0.36 to 0.66, p<0.001), and beliefs that IPV is a 
private matter (aOR 0.54, 95% CI 0.38 to 0.78, p=0.001), 
or should be tolerated (aOR 0.48, 95% CI 0.34 to 0.66, 
p<0.001).
Conclusion These results indicate that the intervention 
was effective in reducing emotional abuse and positively 
impacting attitudes and beliefs condoning IPV, but was not 
sufficient to reduce physical or sexual IPV.
Trial registration number NCT02592252.
Key questions
What is known already?
 ► Global estimates based on prevalence data from 
2000 to 2018 indicate that around a quarter of 
women who have ever been in a relationship have 
experienced physical and/or sexual violence from a 
current or former intimate partner.
 ► There is a growing body of evidence from ran-
domised controlled trials that interventions for 
women that combine social empowerment or gen-
der transformative interventions with economic 
strengthening are effective in preventing intimate 
partner violence.
 ► A previous trial of the MAISHA gender transforma-
tive intervention, delivered to women in established 
microfinance groups, showed a positive impact on 
women’s past- year experience of physical intimate 
partner violence and on their attitudes and beliefs 
about intimate partner violence.
What are the new findings?
 ► In this second trial of the MAISHA intervention, wom-
en living in the same neighbourhood were formed 
into groups to receive the intervention. There was 
a positive impact on women’s attitudes and beliefs 
about violence, and on their past- year experience of 
emotional abuse from an intimate partner.
 ► Though there were anecdotal reports from interven-
tion arm women of improvements in their relation-
ships, the intervention did not lead to measurable 
reductions in their past- year experiences of physical 
or sexual intimate partner violence.
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INTRODUCTION
Violence against women has been described by WHO as a 
‘global public health problem of epidemic proportions’.1 
The most common form of violence against women is 
intimate partner violence (IPV) with the most recent 
estimates from population surveys indicating that, world-
wide, around a quarter of women have experienced phys-
ical and/or sexual violence from an intimate partner in 
their lifetime.2 The negative impacts of IPV on physical 
and mental health are considerable for women and their 
families.1 3–5
There is a growing body of rigorous evidence demon-
strating that IPV is preventable.6 7 Much of this research 
has been conducted in sub- Saharan Africa,8 which is 
among the world regions with the highest rates of IPV.9 
One of the first randomised controlled trials (RCTs) 
was the Intervention with Microfinance for AIDS and 
Gender Equity (IMAGE) trial, implemented in rural 
South Africa.10 The intervention combined group- based 
microfinance with a participatory gender and HIV 
training programme. In a cluster RCT IMAGE was shown 
to reduce women’s past year experience of physical and/
or sexual IPV by 55% over a 2- year period. In addition, 
levels of household poverty were significantly reduced, 
and participants were more empowered as evidenced by 
greater self- confidence, autonomy in decision making, 
and increased ability to challenge gender norms when 
compared with women in the control population.10
Population surveys have revealed high levels of IPV 
against women in Tanzania, with almost 30% of ever- 
partnered women having experienced physical and/
or sexual IPV in the year prior to the survey.11 Recent 
estimates from WHO indicate that violence remains high 
in Tanzania: 38% (95% uncertainty interval: 28%–50%) 
of ever- married or partnered women aged 15–49 years 
have experienced physical and/or sexual IPV in their 
lifetime, and 24% (95% uncertainty interval: 16%–35%) 
have experienced it in the past 12 months.2 Effective 
prevention interventions are urgently needed to address 
this public health crisis. Because the IMAGE model was 
a combined microfinance- training intervention, it was 
difficult to know the extent to which the observed effect 
on IPV was attributable to the different components of 
the intervention. Inspired by the IMAGE study, we aimed 
to better understand the relative and combined effects 
of economic and social empowerment interventions in 
Tanzania on women’s experience of IPV. We previously 
reported the results of a trial investigating the effect of 
the MAISHA social empowerment group- based interven-
tion on experiences of IPV among women taking part in 
a microfinance loan scheme. We found that the interven-
tion was associated with a reduction in reported physical 
or sexual IPV, although the effect was greater for physical 
IPV.12 In this second separate trial, we assessed the effect 
of the same intervention on experiences of IPV among 
women living in the same neighbourhood who were not 
engaged in a formal microfinance loan scheme.
METHODS
Trial design
We conducted a cluster RCT in Mwanza city, north- 
western Tanzania in close collaboration with local commu-
nity leaders. The background, design and methods are 
described in detail elsewhere.13 The trial team worked 
with community leaders to identify suitable neighbour-
hoods across the city in which to form groups of women 
who would be eligible to participate in the trial. Once a 
potential neighbourhood had been identified, MAISHA 
team members worked with local leaders to identify and 
visit households in the neighbourhood in order to invite 
potentially eligible women to attend information meet-
ings. Women who were interested in taking part were 
invited to attend subsequent meetings to obtain detailed 
information about the trial, including the overall aim 
and objectives, eligibility criteria and trial procedures.13
Women were eligible for inclusion if they were aged 
20–50 years, resident in Mwanza for 2 years or more, not 
a member of formal microfinance loan group scheme 
in the past 12 months, and were fluent in Swahili. We 
excluded women who were formally employed so the 
population would be more comparable with the previous 
MAISHA CRT01 trial population,12 and be available to 
attend intervention sessions. Research staff met with 
potentially eligible women to go through the participant 
information sheet explaining the purpose of the trial and 
the procedures. Women who demonstrated comprehen-
sion of the trial procedures and agreed to take part were 
invited to sign the consent form (online supplemental 
material 1). Within each neighbourhood, we aimed to 
recruit around 15–20 women.
Safety
The trial was designed following WHO recommenda-
tions on researching violence against women.14 To ensure 
women’s safety, trained staff interviewed participants 
in private, and maintained regular contact with them 
throughout the trial. A referral system was established 
to assist women who reported experiencing violence to 
access appropriate services and support. Information 
about local support services was provided to all partici-
pants irrespective of whether they reported experiencing 
violence.
Key questions
What do the new findings imply?
 ► This trial, combined with the first MAISHA trial, provides evidence 
that while a gender transformative intervention alone may not be 
sufficient to reduce physical or sexual intimate partner violence, 
the same intervention in the context of economic strengthening of 
women is effective in reducing physical violence.
 ► These findings add to mounting evidence that combining gender 
transformative interventions with economic strengthening pro-
grammes has a positive impact on intimate partner violence.
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Randomisation and masking
Over 18 months, women in 66 neighbourhoods were 
recruited and the neighbourhood clusters then 
randomised in blocks of six as they were enrolled into 
the trial. For each block of six neighbourhood clusters, 
community randomisation ceremonies were conducted 
as a two- stage process that was both participatory and 
transparent involving the research team and represent-
atives nominated by members from each of the neigh-
bourhood clusters to be randomised. First, representa-
tives from each of the six clusters were randomly divided 
equally into two sets (A and B). This was done by each 
representative drawing a folded sheet of paper (with A or 
B written on it) from a box. Second, one of the represent-
atives from either A or B was asked to call (heads or tails) 
for her set to be allocated to immediate intervention. A 
trial team member then tossed a coin to randomly allo-
cate each set of three clusters to either the intervention 
or to control (to receive the intervention after the trial). 
It was not possible to mask participants or the research 
team involved in day- to- day operations and delivery of 
the intervention.
Procedures
The trial timeline is outlined in figure 1. Prior to rando-
misation, we conducted a face- to- face interview with each 
participant using a structured questionnaire adapted 
from the WHO Violence Against Women instrument,11 
which has also been widely used in Demographic and 
Health Surveys and other IPV prevention interven-
tion trials.10 15 16 The questionnaire was translated into 
Swahili (the national language) and independently back- 
translated into English for validation. Interviews were 
conducted in private by female interviewers trained in 
interviewing techniques, gender issues, violence and 
ethical issues related to research on IPV.14
Women in neighbourhoods allocated to the inter-
vention arm participated as a group in the 10- session 
MAISHA intervention following the Wanawake na Maisha 
(which means ‘women and life’ in Swahili) curriculum, 
which was developed by EngenderHealth (an inter-
national non- profit organisation focussing on gender 
equity and reproductive health—www. engenderhealth. 
org) in collaboration with the research team, drawing 
on other published curricula, including Sisters for Life 
from IMAGE. The MAISHA intervention was designed to 
be participatory and reflective, and aimed to empower 
women, prevent IPV, and promote healthy relationships 
by: increasing knowledge and awareness (eg, of the 
consequences of normative attitudes to gender and IPV); 
developing relationship skills (eg, communication and 
conflict resolution); and improving group dynamics and 
stability (eg, increased peer support and social capital).
The 10- session MAISHA intervention (outlined in 
figure 2) was delivered to the 33 intervention arm groups 
on alternate weeks over a 20- week period. Each session 
lasted between 1.5 and 2 hours. Venues were selected 
to be convenient to participants, with sessions generally 
taking place at the group leader’s house or in a quiet area 
of a local café or guesthouse. Sessions were delivered by 
trained female facilitators, following the Wanawake Na 
Maisha curriculum which provides detailed guidance for 
each session. Facilitators were recruited and trained by the 
research team and EngenderHealth, allowing them time 
to become very familiar with the curriculum materials 
and to practise and develop effective facilitation skills. 
Refresher training was provided by EngenderHealth 
during the trial. Intervention delivery was monitored by 
the trial coordinator and senior research team members. 
Curriculum facilitators maintained session attendance 
registers to monitor attendance and ensure that sessions 
were attended by intervention arm women only, thereby 
minimising the potential for contamination.
The curriculum facilitators had no contact with women 
in neighbourhoods allocated to the control arm. However, 
to minimise the risk of attrition bias, the research team 
maintained regular contact with both intervention and 
control arm women during the 2- year period between 
the end of the intervention and assessment of outcomes. 
The impact of the intervention was assessed through 
interviews conducted 29 months postrandomisation 
with both trial arms (24 months after groups completed 
intervention activities). Interviews were conducted face- 
to- face using the same structured questionnaire as at 
baseline, and following the same procedures. Wanawake 
Na Maisha curriculum facilitators were not involved in 
collection of baseline data or trial outcome assessments.
Outcomes
The primary outcomes were women’s reports of past 
year physical IPV and past- year sexual IPV. The original 
primary outcome was a composite of past year physical 
and sexual IPV. However, this was revised in light of the 
results of MAISHA CRT0112 and evidence from other 
violence prevention trials15 16 indicating limited impact 
on sexual IPV, a pattern that was hypothesised from the 
outset of the SASA! trial.17 It was decided, therefore, that 
reported past year experience of physical IPV and sexual 
IPV should be evaluated as separate primary outcomes 
at 29 months postrandomisation (24 months postint-
ervention). A favourable opinion for this amendment 
was received from the ethics committee before the end 
of follow- up and prior to analysis of data. Secondary 
outcomes were emotional abuse, three measures of IPV 
related attitudes and beliefs, and past year disclosure of 
IPV among women who reported past year experience of 
physical/sexual IPV. Details of questionnaire items used 
to construct the outcomes are presented in Table 1.
Sample size
It was calculated that a sample size of 33 neighbourhood 
clusters per trial arm with an average of 20 participants 
per cluster (allowing for 10% loss to follow- up) would 
provide 80% power to detect a reduction of 33% in past 
year IPV, and 90% power to detect a reduction of 38%, 
assuming an intracluster correlation (ICC) of 0.035. Even 
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with an ICC of 0.05, the trial would have 80% power to 
detect a reduction in past year physical IPV of 35%.
Data management and statistical analyses
All data collected at baseline and at follow- up were 
recorded directly onto tablet computers with in- built 
checks to minimise missing or erroneous data. At the 
end of each day, data were uploaded from the tablet 
computers to a secure database and checked by the data 
manager. Data queries were sent to the field team leader 
to be resolved with the data collectors. Data analysis 
was performed using STATA V.16 following a prespeci-
fied analysis plan (online supplemental material 1), by 
analysts who were blind to cluster allocation. The primary 
analysis was conducted following the intention- to- treat 
(ITT) principle, whereby participants were analysed 
according to the trial arm to which they were randomly 
allocated, irrespective of whether or not they participated 
in the intervention (or control) activities. All participants 





Reported that her current or any other partner has done at least one of the following things 
to her in the past 12 months:
 ► Slapped her or thrown something at her that could hurt her.
 ► Pushed her or shoved her or pulled her hair.
 ► Hit her with his fist or something else that could hurt her.
 ► Kicked her, dragged her or beat her up.
 ► Choked or burnt her on purpose.
 ► Threatened to use or actually used a gun, knife or other weapon against her.
Sexual IPV (primary)
(yes/no)
Reported that at least one of the following things has happened to her in the past 12 
months:
 ► Current or any other partner forced her to have sexual intercourse by threatening her, 
holding her down or hurting her in some way.
 ► She had sexual intercourse when she did not want to because she was afraid that her 
partner would hurt her or someone she cared about if she refused.
 ► She had sexual intercourse when she did not want to because she was afraid that her 
partner would leave her or take another girlfriend if she refused.
Emotional abuse*
(yes/no)
Reported that her current or any other partner has done at least one of the following things 
to her in the past 12 months:
 ► Insulted her or made her feel bad about herself
 ► Belittled or humiliated her in front of other people.
 ► Done things to scare or humiliate her on purpose (eg, by the way he looked at her, by 
yelling and smashing things).
 ► Verbally threatened to hurt her or someone she cares about.
Disclosure of IPV (among women 
who physical and/or sexual IPV 
in the past 12 months)
(yes/no)
Reported that she has told someone within the past 12 months about her partner’s 
behaviour (violence/abuse) towards her.
Attitudes accepting of IPV
(yes/no)
Reported that she ‘strongly agrees’ or ‘agrees’ that a man has good reason to hit his wife in 
at least one of the following scenarios:
 ► She does not complete her household work to his satisfaction.
 ► She disobeys him.
 ► She refuses to have sexual intercourse with him.
 ► She protests because he has other girlfriends.
 ► He suspects that she is unfaithful in marriage.
 ► He finds out that she has been unfaithful in marriage.
Believes a woman should 
tolerate violence in order to keep 
her family together
Reported that she ‘strongly agrees’ or ‘agrees’ with the statement:
‘A woman should tolerate violence in order to keep her family together’
Believes IPV is a private matter Reported that she ‘strongly agrees’ or ‘agrees’ with the statement:
‘Violence between husband and wife is a private matter and others should not intervene.’
*High intensity emotional abuse defined as having experienced at least one of the items many times in the past 12 months.
IPV, intimate partner violence.
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who provided both baseline and follow- up data were 
included in the analysis, to allow for adjustment of base-
line characteristics. The crude intervention effect, odds 
ratio (OR) with 95% CI, for each outcome was estimated 
using a logistic regression model with random intercepts 
for neighbourhood cluster (unit of randomisation) to 
account for the clustered nature of the data. Adjusted 
ORs (aORs) were estimated in the same way, except the 
models included terms for age (modelled as a linear 
effect), baseline measure of the respective outcome, and 
education (secondary/higher vs primary/none).
In a real- world setting, it is inevitable that participants 
will not be able to attend every session. As for the previous 
MAISHA trial, we considered attendance at seven or 
more sessions would constitute a good “dose” of the 
intervention. We, therefore, performed a per- protocol 
analysis in which we restricted the analysis to interven-
tion arm women who attended seven or more interven-
tion sessions, and propensity score matched control arm 
women. Dose response effects on attitudinal outcomes 
were further explored by adding number of interven-
tion sessions (as a linear term) to the logistic regression 
model used for the primary analysis.
We also conducted several sensitivity analyses to assess 
the robustness of the primary analysis: (1) adding a 
random intercepts term for interviewer to control for 
possible heterogeneity in outcome reporting between 
interviewers; and (2) including all participants who 
completed the baseline questionnaire, using multiple 
imputation to simulate missing endline data. Since 
the trial commenced, more sophisticated measures of 
emotional/psychological abuse have been proposed. We, 
therefore, conducted a sensitivity analysis with a measure 
of ‘high intensity psychological abuse’18 in addition to 
the original prespecified measure (table 1).
Changes to the protocol
There were three amendments to the trial protocol 
described in detail elsewhere.13 Briefly, these were: (1) 
outcome assessments, originally planned at 17 months 
postrandomisation (12 months postintervention), were 
extended to 29 months postrandomisation (24 months 
postintervention) to allow comparability with the IMAGE 
trial results; (2) the original trial design was to invite male 
partners of trial participants to participate in a similar 
intervention designed for men. In light of poor accrual 
and poor participation in the intervention by enrolled 
men, the trial design was revised to include only women; 
and (3) the primary outcome was changed as previously 
described.
Participant and public involvement
The design of the MAISHA study was inspired by IMAGE 
and aimed to address questions raised by the trial in 
South Africa. Although there was not specific public 
involvement in development of the research question 
and outcomes, discussions were held with local commu-
nity leaders and representatives about the purpose of the 
study. Throughout the trial, the research team worked 
in collaboration with local community leaders to identify 
neighbourhoods across the city in which to form groups. 
Within each neighbourhood, the research team worked 
closely with local leaders to identify and invite women to 
local community information meetings about the study. 
The process of randomisation was a participatory process 
that involved participant representatives to ensure trans-
parency in allocation of neighbourhoods to each arm of 
the trial.
Community advisory committees were established 
comprising local leaders, religious leaders, trial partici-
pants and other relevant stakeholders. These commit-
tees met regularly to facilitate effective communication 
between the research team and study communities, and 
to ensure that any concerns from members of the commu-
nity were addressed promptly. The COVID-19 pandemic 
has impacted on dissemination activities, however the 
MAISHA team continues to work with the community 
advisory committees on plans to safely disseminate the 
trial results to participants and stakeholders in Tanzania.
RESULTS
Between September 2015 and February 2017, we identi-
fied 81 neighbourhoods and sought approval from local 
leaders to conduct research activities. Research activities 
were discontinued in 15 neighbourhoods when it became 
apparent that high numbers of women were members 
of formal microfinance loan schemes (n=12 neighbour-
hoods) or there were insufficient numbers of women who 
wished to take part (n=3 neighbourhoods). Across the 
remaining 66 neighbourhoods, 1912 women attended 
the information meetings. Of these, 1478 expressed 
interest in participating and were assessed for eligibility, 
of whom 1265 were ultimately enrolled (figure 3). A 
baseline interview was completed prior to randomisation 
by 1248 (99%) women. Between May 2018 and August 
2019, 551 (88%) women in the intervention arm and 
575 (90%) women in the control arm also completed the 
follow- up interview and were included in the ITT analysis 
(figure 3). There was no difference in baseline character-
istics between women included in the ITT and those lost 
to follow- up.
Table 2A shows the baseline characteristics of partici-
pants by trial arm. The mean age of women was similar 
in both arms, around 33 years. Almost all participants 
(n=1123, 99.8%) reported having had a partner (regular 
or casual) at some point in their lives, with most married/
living as married at baseline (80%–81%). The two arms 
were broadly similar, although there was a slight differ-
ence in education, with control arm women more likely 
to have attended secondary or higher education (22% vs 
19%). In addition, control arm women reported higher 
median monthly income compared with intervention 
arm women (table 2A). Table 2B shows participants’ base-
line reports of IPV and attitudes by trial arm. At baseline, 
control arm women were more likely to have reported 
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past year sexual IPV (23% vs 19%) but were less likely to 
have attitudes accepting of IPV compared with interven-
tion arm women (51% vs 58%)(table 2B). The ICC for 
baseline past year physical IPV was 0.0230 (SE 0.0211) 
and for past year sexual IPV 0.0001 (SE 0.0172).
Of the 551 intervention women, 85% (n=466) partic-
ipated in at least seven of the 10 intervention sessions. 
In Table 3A, we present the results of the ITT analyses. 
At follow- up, past year physical IPV was reported by 
21% of intervention arm women and 20% of control 
arm women. The aOR was 0.98 (95% CI 0.72 to 1.33, 
p=0.892). In addition, past year sexual IPV was reported 
by 20% of intervention arm women and 21% of control 
arm women. The aOR was 0.98 (95% CI 0.72 to 1.32, 
p=0.881). With respect to secondary outcomes, there 
was evidence of an impact on past year emotional abuse, 
which was reported by 39% of intervention arm women 
compared with 45% of control arm women (aOR 0.74, 
95% CI 0.56 to 0.98, p=0.035). Furthermore, there was 
also evidence of impact on attitudes accepting of IPV 
(aOR 0.49, 95% CI 0.36 to 0.66, p<0.001), the belief that 
a woman should tolerate violence in order to keep her 
family together (aOR 0.48, 95% CI 0.34 to 0.66, p<0.001), 
and the belief that IPV is private matter and others should 
not intervene (aOR 0.54, 95% CI 0.38 to 0.78, p=0.001). 
Among the women reporting past year physical or sexual 
IPV, results are suggestive of decrease in odds of disclo-
sure of IPV in the intervention arm, however, the CI is 
wide, and inference is severely limited by the restricted 
sample size for this outcome (table 3A).
Measures of effect were not affected by inclusion of a 
random intercepts term for interviewer online supple-
mental table S1), or when multiple imputation was 
used to impute missing outcome data for participants 
who only completed the baseline questionnaire (online 
supplemental table S2). In contrast to when the prespec-
ified measure of emotional abuse was used, there was 
less evidence of an impact on emotional abuse using the 
‘high intensity’ measure (aOR 0.79, 95% CI 0.55 to 1.12).
As with the ITT analysis, there was no impact on the 
primary outcomes when the analysis was restricted to 
women who participated in seven or more sessions and 
propensity scored matched controls (per- protocol anal-
ysis, Table 3B). While intervention impacts on the attitu-
dinal outcomes were similar in this ‘high- dose’ group to 
those observed in the ITT analysis, the effect on emotional 
abuse was slightly stronger in the high dose group (aOR 
of 0.65, 95% CI 0.48 to 0.87, p=0.004), (table 3B). We 
found no evidence of a dose response effect on attitu-
dinal outcomes among intervention arm women who 
attended one or more sessions (online supplemental 
figures S1-3 and table S3).
There were no reports that participation in the trial had 
led to new episodes of violence or worsening of ongoing 
violence and abuse. The trial team provided assistance 
to 43 women who wished to seek help and support for 
ongoing IPV and abuse.
DISCUSSION
In this trial, we found no evidence of an impact on either 
reported past year physical or sexual IPV among women 
who participated in the MAISHA intervention. There was, 
however, evidence of a reduction in past- year emotional 
abuse, and intervention women were much less likely to 
express attitudes accepting of IPV, express beliefs that 
IPV is a private matter, or that a woman should tolerate 
IPV in order to keep her family together.
The lack of an effect on past- year physical IPV is in 
contrast to the findings of a previous trial we conducted 
evaluating the impact of the MAISHA social empower-
ment intervention among women taking part in a formal 
microfinance scheme (MAISHA CRT01), where physical 
Figure 3 Trial profile. ITT, intention- to- treat.
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Age (years) Mean (SD) (range) 33.2 (8.1) (20–50) 33.0 (8.0)(18–50)
Marital status Married 445 (81%) 461 (80%)
  Divorced/separated 52 (9%) 62 (11%)
  Widowed 26 (5%) 26 (5%)
  Never married 28 (5%) 26 (5%)
Partnered in past year   503 (91%) 527 (92%)
Highest level of education completed None/incomplete primary 100 (18%) 114 (20%)
  Completed primary 344 (62%) 336 (58%)
  Attended secondary/higher 107 (19%) 125 (22%)
Partner’s age (years) Mean (SD) (range) 39.6 (9.6)(20–77) 39.4 (9.5)(22–68)
Partner’s education None/incomplete primary 45 (8%) 36 (6%)
  Completed primary 332 (60%) 331 (58%)
  Attended secondary or 
higher
153 (28%) 178 (31%)
  Unknown 19 (3%) 29 (5%)
No of children
(<18 years)
None 24 (4%) 29 (5%)
  1–2 186 (34%) 234 (41%)
  3–4 225 (41%) 213 (37%)
  5+ 116 (21%) 99 (17%)
Household experienced financial hardship in past year 385 (65%) 344 (60%)
Respondent worked for money during past 12 months 443 (80%) 461 (80%)
Respondent’s monthly income (Tanzanian shillings) Median
(IQR)
88 000*
(55 000 to 154 000)
110 000†
(55 000 to 195 000)
*Equivalent to approximately US$38 (US$24 to US$66).
†Equivalent to US$47 (US$24 to US$84).
Table 2B Baseline reports of intimate partner violence, and attitudes and beliefs among ever- partnered participants included 
in the intention- to- treat analysis, by trial arm






  Ever 320 (58%) 325 (57%)
  Past year 141 (26%) 140 (24%)
Sexual
  Ever 215 (39%) 239 (42%)
  Past year 105 (19%) 130 (23%)
Emotional
  Ever 407 (74%) 406 (71%)
  Past year 249 (45%) 252 (44%)
Disclosed violence in past year (among those experiencing physical/sexual IPV 
in past year)
138/187 (74%) 147/203 (72%)
Attitude/belief (N=551) (N=575)
Attitudes accepting of IPV 319 (58%) 296 (51%)
Believes a woman should tolerate violence in order to keep her family together 496 (90%) 497 (86%)
Believes IPV is a private matter and others should not intervene 64 (12%) 69 (12%)
*Three women (intervention n=2, control n=1) reported at baseline never being partnered, so excluded from the analysis.
IPV, intimate partner violence.
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IPV was reduced by around a third.12 There are several 
potential reasons for these contrasting findings.
First, important differences in the underlying risk 
factors for IPV of the two trial populations could explain 
the different intervention effects observed. Women 
(and their partners) in the current trial were on average 
younger than those in the previous trial (women’s mean 
age at baseline 33.1 years, (SD 8.1 years) vs 39.6 years, 
Table 3A Intention- to- treat analysis of intervention impact on primary and secondary outcomes reported 29 months 
postrandomisation among ever partnered women







Crude OR (95% CI) p 
value
Adjusted OR
(95% CI) p value
Physical (primary) 113 (21%) 117 (20%)   1.1 (0.75 to 1.36)
  0.934
0.98 (0.72 to 1.33)
0.892
Sexual (primary) 109 (20%) 121 (21%) 0.93 (0.69 to 1.26)
0.648
0.98 (0.72 to 1.32)
0.881
Emotional 216 (39%) 259 (45%) 0.79 (0.61 to 1.03)
0.079
0.74 (0.56 to 0.98)
0.035
  n=170 n=177     
Disclosed IPV in past year (among those 
experiencing physical/sexual IPV in past year)
118 (69%) 135 (76%) 0.71 (0.44 to 1.14)
0.151
0.75 (0.46 to 1.21)
0.239
Attitude/belief (n=551) (n=575)     
Attitudes accepting of IPV 282 (51%) 373 (65%) 0.56 (0.42 to 0.74)
<0.001
0.49 (0.36 to 0.66)
<0.001
Believes a woman should tolerate violence in 
order to keep her family together
82 (15%) 148 (26%) 0.50 (0.37 to 0.69)
<0.001
0.48 (0.34 to 0.66)
<0.001
Believes IPV is a private matter and others should 
not intervene
58 (11%) 100 (17%) 0.56 (0.39 to 0.81)
0.002
0.54 (0.38 to 0.78)
0.001
*One woman reported never being partnered so excluded from the analysis.
IPV, intimate partner violence.
Table 3B Intervention impacts on primary and secondary outcomes among those attending seven or more intervention 
sessions, compared with controls matched on propensity for high intervention attendance*











Physical 95 (20%) 98 (21%) 0.96 (0.70 to 1.32)
0.808
0.96 (0.69 to 1.34)
0.812
Sexual 91 (20%) 98 (21%) 0.92 (0.65 to 1.29)
0.616
0.97 (0.70 to 1.36)
0.873
Emotional 171 (37%) 214 (46%) 0.68 (0.51 to 0.90)
0.008
0.65 (0.48 to 0.87)
0.004
Disclosed violence in past year (among those 
experiencing physical/sexual IPV in past year)
99/142 (70%) 109/145 (75%) 0.76 (0.45 to 1.29)
0.305
0.80 (0.47 to 1.38)
0.425
Attitude/belief     
Attitudes accepting of IPV 235 (51%) 296 (64%) 0.57 (0.42 to 0.78)
<0.001
0.51 (0.37 to 0.71)
<0.001
Believes a woman should tolerate violence in 
order to keep her family together
69 (15%) 123 (27%) 0.48 (0.34 to 0.69)
<0.001
0.47 (0.33 to 0.67)
<0.001
Believes IPV is a private matter and others should 
not intervene
48 (10%) 84 (18%) 0.52 (0.35 to 0.78)
0.001
0.52 (0.35 to 0.77)
0.001
*Propensity score predicted based on a logistic regression model fitted to women in the intervention arm, with 7+ sessions as the 
dependent variable and independent variables comprising baseline measures of cluster size, age, religion, marital status, highest level 
of education attended, number of children, experience of sexual and/or physical IPV (never/ ever but not past yr/ past year), past year 
experience of controlling behaviour, and poor mental health.
†Crude OR point and interval estimates and p value are from a logistic regression with cluster- level random intercepts but no 
adjustment for baseline covariates.
‡Adjusted OR point and interval estimates and p- value are from a logistic regression with cluster- level random intercepts and 
adjustment for baseline measure of outcome (Y/N/NA), secondary or higher education (Y/N) and age (linear).
IPV, intimate partner violence.
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(9.5 years)), and reported higher levels of past year phys-
ical and/or sexual IPV at baseline (35% vs 26%). Another 
key difference between the two populations is level of 
education, which is well- recognised as a risk factor for 
IPV.19 Overall, participants in the current trial were less 
educated with 19% having received no education or 
incomplete primary education compared with 14% of 
CRT01 participants.12 Having less formal education does 
not seem to have impacted on women’s participation in 
the intervention; the facilitators reported that women 
were very engaged and interactive during the sessions. 
However, they may have faced more challenges in imple-
menting changes at home to reduce violence.
Second, participants in the previous trial were recruited 
and participated in the MAISHA intervention in their pre- 
established microfinance groups. It is likely, therefore, that 
they had already developed strong social ties with their fellow 
group members. Evidence suggests that social capital, such 
as that gained through group membership, may provide 
women with some forms of protection, as well as the confi-
dence to address physical IPV.20 It is possible that this support 
combined with a slightly higher level of formal education, 
meant that these women were already further along a trajec-
tory of empowerment at the outset of the trial, that is, thinking 
about and challenging social norms that promote gender 
inequalities.21 Conversely, for the current trial, women 
living in the same neighbourhood were formed into groups 
specifically for the purpose of the intervention, and may not 
have had pre- existing social ties with other group members. 
Perhaps these women needed more time to bond as a group 
and develop social trust and solidarity before participating in 
the MAISHA intervention. Even so, we are aware that there 
were tensions within some of the microfinance groups over 
the collective responsibility for individual debt, which some-
times impacted negatively on group cohesiveness.
Third, in addition to being less educated than women 
in the previous trial, other indicators suggest that women 
in the current trial experienced greater levels of poverty. 
They were more likely to report household economic hard-
ship, as measured by difficulty in covering basic household 
needs such as food and medicine (62% vs 47%). The rela-
tionship between poverty and women’s experience of IPV is 
complex and the evidence suggests multiple ways in which 
poverty drives IPV both directly and indirectly.19 Indirectly, 
growing up in poverty increases the likelihood of experi-
encing recognised risk factors for IPV, including poorer 
educational outcomes, and adverse childhood experi-
ences such as physical, sexual and emotional abuse, and 
neglect.22 23 More directly, high levels of stress in households 
struggling to manage scarce resources, can lead to conflict 
and violence.24 25 A number of studies have demonstrated 
associations between food insecurity (an indicator of acute 
poverty) and women’s experience of IPV.19 23 26 Any effects 
of the MAISHA intervention may not have been sufficient to 
counteract these additional stressors present in the current 
trial.
Fourth, as well as overall levels of household poverty, 
women’s lack of access to and control over economic 
resources is also a driver of IPV risk, limiting women’s power 
within relationships as well as their ability to leave abusive 
relationships. Women in the current trial were not partici-
pating in formal microfinance, were less likely than those in 
the previous trial to report personally earning money (80% vs 
97%), and where they did so their income was lower (median 
of 110 000 vs 220 000 Tanzanian shillings per month). Starting 
from a point of greater financial independence from their 
male partners, the MAISHA intervention may have enabled 
women in the previous trial to enact change within their rela-
tionships. For women in the current trial, however, greater 
economic dependence on male partners might have limited 
the extent to which they were able to translate changes in 
personal ‘empowerment’ into relationship- level change.
Given the ways in which poverty increases women’s 
vulnerability to IPV, there has been considerable research 
focused on economic interventions to prevent women’s 
experience of IPV.7 Much of the research addresses whether 
economic interventions alone are sufficient to reduce IPV, 
or whether they should be delivered in combination with 
social empowerment or gender transformative interven-
tions. The evidence indicates that programmes combining 
economic strengthening with social empowerment for 
women tend to lead to positive outcomes,7 27 with cash 
transfer interventions more consistently linked to reduc-
tions in IPV than microfinance interventions for which the 
evidence is more mixed.28 The related but conceptually 
opposite question of whether social empowerment inter-
ventions alone can work in the absence of economic inter-
ventions, has received less attention. This trial suggests that 
a social empowerment intervention alone for women is not 
sufficient to reduce IPV. However, we cannot comment on 
whether these results can be generalised to other women 
in Tanzania. For example, women in higher socioeco-
nomic groups.
It is possible that we might have seen an intervention 
effect on physical and sexual violence if male partners 
had also participated in the intervention, as originally 
planned. There is good evidence that couples’ interven-
tions, which are well designed and well implemented, 
are effective in reducing IPV against women.7 Such inter-
ventions require careful consideration of the population 
being targeted, including understanding how mascu-
linities operate and are related to IPV perpetration in 
specific contexts.26
The MAISHA intervention had a considerable impact 
on women’s attitudes and beliefs about violence. Although 
we cannot exclude the possibility of social desirability bias, 
it is worth noting anecdotal evidence from the field team 
suggesting that women seemed more confident about chal-
lenging violence in their communities.
Similar to the previous MAISHA trial and other trials,15 
there was no effect on sexual IPV in this trial. We did not 
assess women’s acceptance of sexual IPV, however, social 
norms supporting sexual entitlement of men are deeply 
entrenched in Tanzania. The lack of impact on sexual IPV in 
both MAISHA trials indicates the need to engage more with 
men. Although they did not refer to sexual IPV explicitly, 
 on A









ealth: first published as 10.1136/bm




12 Harvey S, et al. BMJ Global Health 2021;6:e004555. doi:10.1136/bmjgh-2020-004555
BMJ Global Health
the trial participants highlighted the need to include men in 
violence prevention interventions.
In contrast to the previous trial there was a reduction in 
reports of emotional abuse by intervention arm women 
compared with control arm women. This is an encour-
aging finding given the link between mental ill health and 
emotional abuse.29 The overall prevalence of emotional 
abuse was high in both MAISHA trial populations; however, 
it is not clear why there was an impact of the intervention on 
this form of abuse in the current trial but not in the previous 
trial. Secondary analyses are underway to explore potential 
explanations for the different intervention effects in the two 
trials, alongside questions of how mechanisms of change 
may have differed in the two trials. These exploratory anal-
yses augmented by rich data from the longitudinal qualita-
tive study of a subsample of trial participants,21 will provide 
valuable insights into these results, and provide an oppor-
tunity to better understand the potential for the MAISHA 
intervention to be transferred and adapted to other settings.
We observed a slightly stronger effect on emotional abuse 
when we restricted the analysis to women who attended 
seven or more sessions; however, we did not observe any 
strengthened impact on other outcomes in this ‘high- dose’ 
group. This is perhaps unsurprising given the high atten-
dance at sessions, which of itself is encouraging and suggests 
the MAISHA intervention is acceptable to women.
There are some limitations. Women who participated 
in the trial are among the poorest in Mwanza city, and 
the results are possibly not generalisable to women who 
are more economically advantaged. Reporting bias is a 
concern, particularly as under- reporting of IPV is common. 
It is possible that exposure to the intervention might have 
increased sensitisation of women to IPV leading to increased 
reports of violence among women in the intervention arm, 
and thereby an underestimate of the effect size. Given the 
nature of the intervention, it was not possible to mask the 
research team to group allocation. To reduce the risk of 
reporting bias, we assessed outcomes using questions that 
are standardised and widely used in violence research11 with 
face- to- face interviews conducted by interviewers who had 
received extensive training and had not been involved in 
implementation of the intervention.
The trial has many strengths. Randomisation of groups 
ensured that there was no bias in programme placement. 
Women were enrolled from a large number of neigh-
bourhoods across Mwanza city ensuring that the trial was 
adequately powered. Engagement with the intervention was 
very good and most participants attended at least seven of 
the 10 sessions, suggesting that the intervention is acceptable 
to women. Retention rates were high for both arms (88% 
intervention arm vs 90% control). Although it is possible that 
the women lost to follow- up differed from those included in 
the analysis, baseline comparisons with the ITT population 
do not support this suggestion. Furthermore, the impact of 
the intervention remained much the same when those lost 
to follow- up were included in the outcomes analysis using 
multiple imputation. Data were analysed following the ITT 
principle and a pre- specified analysis plan, with data analysts 
blinded to trial allocation. Baseline data enabled us to adjust 
for baseline imbalances between the trial arms (according to 
the pre- specified analysis plan). The mixed- methods design 
of the trial, utilising quantitative and qualitative approaches, 
will allow us to gain a better understanding of the effect of 
the intervention, and how it is experienced by participants. 
Data from the complementary longitudinal qualitative study 
will be invaluable in exploring women’s experiences of the 
intervention and format, processes of change, and potential 
reasons for its impact or lack of impact on different forms of 
violence and abuse.
In summary, IPV is a major problem globally. This trial is 
an important addition to the body of evidence on what works 
to prevent violence.6 7 It has shown that although this gender 
transformative intervention did have a considerable impact 
on attitudes and beliefs about violence, and on emotional 
abuse experienced by women, it was not sufficient to reduce 
physical or sexual IPV. Current evidence indicates positive 
outcomes when social empowerment or gender transfor-
mative interventions are combined with economic strength-
ening for women.7 27 However, it is also crucial to engage men 
in strategies to prevent all forms of violence against women, 
and there is accumulating evidence that couples’ interven-
tions, focussing on transforming gender relations within the 
couple, are also effective in reducing women’s experiences 
of IPV.7
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